Aged rat myocardium maintains normal adenosine receptor responsiveness and exhibits enhanced cardioprotection (infarct size reduction) from adenosine agonists compared to adult myocardium.
Answers are grounded in this paper and cite their sources.
Greater AMP579-mediated infarct size reduction in aged rats; leaves open translation of adenosine agonist cardioprotection to elderly patients.
The purpose of this study was to determine whether aged myocardium exhibits decreased responsiveness to adenosine A1 and A(2a) receptor activation. Studies were conducted in adult (4-6 months) and aged (24-26 months) Fischer 344 x Brown Norway hybrid (F344 x BN) rats. Effects of the adenosine A1/A(2a) agonist AMP579 were measured in isolated hearts and in rats submitted to in vivo regional myocardial ischemia. Aged isolated hearts exhibited lower spontaneous heart rates and higher coronary resistance, as well as normal A1- and A(2a)-mediated responses. There was no difference in control infarct size between adult and aged rats; however, AMP579 treatment resulted in a 50% greater infarct size reduction in aged rats (18 +/- 4% of risk area) compared to adult rats (37 +/- 3%). These findings suggest that adenosine A1 and A(2a) receptor-mediated effects are not diminished in normal aged myocardium, and that aged hearts exhibit increased adenosine agonist-induced infarct reduction.
No takes yet. Share an insight, caveat, or question.
Kristo et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: